Missouri Cardiovascular Specialists

Columbia, Missouri 65201-8023

0 studies enrolling now · 13 studies all time

What they study most

ASCVD, Acute Coronary Syndrome, Acute Coronary Syndromes, Atrial Fibrillation, Chronic Total Occlusion, Chronic Total Occlusion of Coronary Artery, Congestive Heart Failure, Heart Failure, Heart Failure, Congestive, Ischemic Heart Disease, Myocardial Infarction, PE - Pulmonary Embolism

Studies at this site

• Personalized Therapy Study - Attain Stability Quad Post-Approval Study — Running, not enrolling
• Personalized Therapy Study - Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS) — Running, not enrolling
• Personalized Therapy Study - HFRS (TriageHF) Post Approval Study — Running, not enrolling
• FlowTriever All-Comer Registry for Patient Safety and Hemodynamics — Completed
• Chronic Total Occlusion Percutaneous Coronary Intervention Study — Completed
• The Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9 Inhibitors (cvMOBIUS) — Stopped early
• Personalized CRT - MPP Post Approval Study — Completed
• A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart — Completed
• IMPROVE HF: Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting — Completed
• A Phase III Study of Apixaban in Patients With Atrial Fibrillation — Completed
• Phase III Acute Coronary Syndrome — Stopped early
• Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure — Stopped early
• EVEREST: Efficacy of Vasopressin Antagonism in hEart failuRE: Outcome Study With Tolvaptan — Completed